EMJ

EMJ #1 open access destination for HCPs & Pharma globally. Peer-reviewed journals & diverse content hub. Interviews, podcasts, webinars, infographics.

EMJ is the number one open access destination for HCPs and Pharma professionals globally. We do this across 18 therapy areas and the pharmaceutical sector via EMJ GOLD. We use industry-leading digital tools, to meet the challenges of time-poor medical professionals with a real passion to learn and in turn to elevate the quality of healthcare globally. Our content builds trust between healthcare professionals and Pharma, to help them continuously improve together. At the core of our content hub is a portfolio of peer reviewed, open access journals, which are complemented by alternative formats such as interviews, podcasts, webinars, and infographics. We have built our incredible team by recruiting on values. We stay true to these values in everything we do, as we remain steadfast in our goal to create Gold Medal Winners. For trusted partners who share our vision, we invite you to get in touch and join us on our journey.

Could a low-dose strategy be the key to treating children who were previously told they were too high-risk for allergy t...
01/01/2026

Could a low-dose strategy be the key to treating children who were previously told they were too high-risk for allergy therapy?

Learn more:

A study shows very low-dose oral immunotherapy safely improves tolerance to multiple nuts in children with food allergies. Find out more about this approach.

New study finds that medical care does not always align with patients' goals at the end of life.Researchers analysed sur...
31/12/2025

New study finds that medical care does not always align with patients' goals at the end of life.

Researchers analysed survey responses from over 1,000 adults to determine whether care during advanced illness prioritises comfort or life extension.

Uncover the findings:

Researchers analysed survey responses from more than 1,000 adults taking part in a large multisite trial of advance care planning.

What does a new UK trial tell us about the promise of immune-based strategies for treating early Parkinson's disease?Fin...
30/12/2025

What does a new UK trial tell us about the promise of immune-based strategies for treating early Parkinson's disease?

Find out on EMJ:

Keep reading to learn why an immune therapy trial did not slow early Parkinson's disease progression.

🚭 E-cigarette use may increase the risk of heart attack and stroke.A large systematic review and meta-analysis of over 1...
27/12/2025

🚭 E-cigarette use may increase the risk of heart attack and stroke.

A large systematic review and meta-analysis of over 1.5 million people found higher rates of myocardial infarction and stroke among e-cigarette users - with particularly elevated risk in former smokers who v**e.

The findings challenge assumptions about cardiovascular safety and highlight the need for caution in clinical guidance.

Read more 🔗https://hubs.la/Q03YWLHy0"

New meta-analysis finds e-cigarette use may increase the risk of heart attack and stroke, even after adjusting for cigarette smoking.

Can a vaccination for pneumonia also protect your gut?  A recent study suggests that pneumococcal vaccination reduces th...
26/12/2025

Can a vaccination for pneumonia also protect your gut?

A recent study suggests that pneumococcal vaccination reduces the colonisation of antibiotic-resistant bacteria and the potential disruption of the gut flora.

Understand why: https://hubs.la/Q03YSn6t0

24/12/2025

Why do we need national cystic fibrosis (CF) registers globally?

This series with Nicholas Simmonds explores advances in CF therapies, the vital role of national CF registries, and how CF shows up in adulthood.

Watch here: https://hubs.la/Q03YQ_lw0

24/12/2025

Uncover the biggest highlights in Oncology this year, with key insights from leading clinicians across the field. In this highlights episode, Catherine Glass explores cutting-edge developments in oncology this year including the evolution of clinical trial management.

Listen here: https://hubs.la/Q03Y-HZn0

Ni****ne withdrawal heightens pain sensitivity in smokers, who require substantially more postoperative analgesics than ...
23/12/2025

Ni****ne withdrawal heightens pain sensitivity in smokers, who require substantially more postoperative analgesics than non-smokers.

Learn more: https://hubs.la/Q03YSkgb0

22/12/2025

🎁 Challenge accepted? EMJ's Quiz of the Year is officially UNWRAPPED!

2025 brought us incredible breakthroughs, pivotal trial data, and therapeutic advances that changed patient care. How many do you remember?

Test your clinical knowledge with our interactive Year in Review quiz - featuring month-by-month highlights, expert insights, and instant scoring.

Play now: https://hubs.la/Q03YT9XX0

A major 4-year study shows that daily social media use can lead to small, gradual inattention increases for children.Rea...
22/12/2025

A major 4-year study shows that daily social media use can lead to small, gradual inattention increases for children.

Read the full study: https://hubs.la/Q03YS7jH0

Have you seen our Winter Flagship journal publication yet?  Inside, uncover expert insights from our esteemed Editorial ...
22/12/2025

Have you seen our Winter Flagship journal publication yet?

Inside, uncover expert insights from our esteemed Editorial Board below:

- Prof Markus Peck-Radosavljevic, Klinikum Klagenfurt am Wörthersee
- Prof Lászlo Vécsei, University of Szeged
- Prof Abdullah Erdem Canda, Yildirim Beyazit University
- Prof Ahmad Awada, Jules Bordet Institute

Read the journal free today: https://hubs.la/Q03YRdxK0

What did our readers find most interesting this year? Discover more below.🍺 Quitting Alcohol May Worsen Cholesterol, Dec...
22/12/2025

What did our readers find most interesting this year? Discover more below.

🍺 Quitting Alcohol May Worsen Cholesterol, Decade-Long Study Reveals: https://hubs.la/Q03YQYX20

🧠 Early Detection of Brain Diseases with Speech-Based AI Screening: https://hubs.la/Q03YQZw60

🦴 Chinese Scientists Develop “Bone Glue” for Shattered Fractures: https://hubs.la/Q03YQYRJ0

Address


Opening Hours

Monday 09:00 - 05:00
Tuesday 09:00 - 05:00
Wednesday 09:00 - 05:00
Thursday 09:00 - 05:00
Friday 09:00 - 05:00

Alerts

Be the first to know and let us send you an email when EMJ posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

  • Want your practice to be the top-listed Clinic?

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

EMJ is an independent, open-access eJournal dedicated to delivering first-class insights into ground-breaking changes, and advancements in medicine. Spanning sixteen therapeutic areas, including Innovations, Cardiology, Oncology, and more, each journal provides the reader with the latest medical congress highlights, abstract reviews, and peer-reviewed articles to name but a few of its wide content selection. Flagship EMJ journals are also published quarterly, bringing an assortment of research papers from a variety of topics, alongside unique features and interviews.

The journal actively encourages members of the healthcare community to get involved, and there are plenty of opportunities to do so if you are interested. Featuring an online blog where both medical professionals, and members of the public can actively share their opinions about the most recent medical discoveries, debates, and controversies, EMJ welcomes contributions on relevant and topical subjects. For any members of the medical world who wish to act as editorial board members, peer-review papers, or even contribute articles to EMJ’s journals, then please do take a look at guidelines on the website: http://emjreviews.com/authors/, or get in contact to learn more: editor@emjreviews.com